glp 1 solucion oral para adelgazar GLP-1: Parches frente a suplementos | ¿Cuál elegir? FDA aprueba #orforglipron Primer GLP-1
Description
A PubMed search was conducted to identify systematic reviews or meta-analyses investigating the effects of GLP-1 agonists on physiological and lifestyle factors
Discontinuation: If symptoms are severe, persistent, or suggestive of hypersensitivity, discontinuing the medication may be necessary
Metabolic disorders, particularly type 2 diabetes mellitus (T2DM) and obesity, contribute significantly to this burden, affecting over 460 million people worldwide with diabetes and creating a substantial interplay between metabolic and cardiovascular pathophysiology [1,2]

In contrast, indulgent and discretionary categories are seeing the most significant declines

Monitoring Report: GLP-1 RA Prescribing Trends December 2025 Data | medRxiv
References Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J
